The Market Reports

Index

1 Felbamate Market Overview
1.1 Product Overview and Scope of Felbamate
1.2 Felbamate Segment by Type
1.2.1 Global Felbamate Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Tablet
1.2.3 Oral Solution
1.3 Felbamate Segment by Application
1.3.1 Felbamate Sales Comparison by Application: (2021-2027)
1.3.2 Refractory Lennox-Gastaut Syndrome
1.3.3 Refractory Seizure Disorders
1.3.4 Others
1.4 Global Felbamate Market Size Estimates and Forecasts
1.4.1 Global Felbamate Revenue 2016-2027
1.4.2 Global Felbamate Sales 2016-2027
1.4.3 Felbamate Market Size by Region: 2016 Versus 2021 Versus 2027

2 Felbamate Market Competition by Manufacturers
2.1 Global Felbamate Sales Market Share by Manufacturers (2016-2021)
2.2 Global Felbamate Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Felbamate Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Felbamate Manufacturing Sites, Area Served, Product Type
2.5 Felbamate Market Competitive Situation and Trends
2.5.1 Felbamate Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Felbamate Players Market Share by Revenue
2.5.3 Global Felbamate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Felbamate Retrospective Market Scenario by Region
3.1 Global Felbamate Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Felbamate Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Felbamate Market Facts & Figures by Country
3.3.1 North America Felbamate Sales by Country
3.3.2 North America Felbamate Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Felbamate Market Facts & Figures by Country
3.4.1 Europe Felbamate Sales by Country
3.4.2 Europe Felbamate Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Felbamate Market Facts & Figures by Region
3.5.1 Asia Pacific Felbamate Sales by Region
3.5.2 Asia Pacific Felbamate Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Felbamate Market Facts & Figures by Country
3.6.1 Latin America Felbamate Sales by Country
3.6.2 Latin America Felbamate Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Felbamate Market Facts & Figures by Country
3.7.1 Middle East and Africa Felbamate Sales by Country
3.7.2 Middle East and Africa Felbamate Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Felbamate Historic Market Analysis by Type
4.1 Global Felbamate Sales Market Share by Type (2016-2021)
4.2 Global Felbamate Revenue Market Share by Type (2016-2021)
4.3 Global Felbamate Price by Type (2016-2021)

5 Global Felbamate Historic Market Analysis by Application
5.1 Global Felbamate Sales Market Share by Application (2016-2021)
5.2 Global Felbamate Revenue Market Share by Application (2016-2021)
5.3 Global Felbamate Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Mylan
6.1.1 Mylan Corporation Information
6.1.2 Mylan Description and Business Overview
6.1.3 Mylan Felbamate Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Mylan Product Portfolio
6.1.5 Mylan Recent Developments/Updates
6.2 Alvogen
6.2.1 Alvogen Corporation Information
6.2.2 Alvogen Description and Business Overview
6.2.3 Alvogen Felbamate Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Alvogen Product Portfolio
6.2.5 Alvogen Recent Developments/Updates
6.3 Amneal Pharmaceuticals
6.3.1 Amneal Pharmaceuticals Corporation Information
6.3.2 Amneal Pharmaceuticals Description and Business Overview
6.3.3 Amneal Pharmaceuticals Felbamate Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Amneal Pharmaceuticals Product Portfolio
6.3.5 Amneal Pharmaceuticals Recent Developments/Updates
6.4 Sun Pharma
6.4.1 Sun Pharma Corporation Information
6.4.2 Sun Pharma Description and Business Overview
6.4.3 Sun Pharma Felbamate Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Sun Pharma Product Portfolio
6.4.5 Sun Pharma Recent Developments/Updates
6.5 Cadila Healthcare
6.5.1 Cadila Healthcare Corporation Information
6.5.2 Cadila Healthcare Description and Business Overview
6.5.3 Cadila Healthcare Felbamate Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Cadila Healthcare Product Portfolio
6.5.5 Cadila Healthcare Recent Developments/Updates
6.6 Merck Sharp and Dohme
6.6.1 Merck Sharp and Dohme Corporation Information
6.6.2 Merck Sharp and Dohme Description and Business Overview
6.6.3 Merck Sharp and Dohme Felbamate Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Merck Sharp and Dohme Product Portfolio
6.6.5 Merck Sharp and Dohme Recent Developments/Updates
6.7 Schering Plough
6.6.1 Schering Plough Corporation Information
6.6.2 Schering Plough Description and Business Overview
6.6.3 Schering Plough Felbamate Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Schering Plough Product Portfolio
6.7.5 Schering Plough Recent Developments/Updates
6.8 Corepharma
6.8.1 Corepharma Corporation Information
6.8.2 Corepharma Description and Business Overview
6.8.3 Corepharma Felbamate Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Corepharma Product Portfolio
6.8.5 Corepharma Recent Developments/Updates
6.9 ANI Pharmaceuticals
6.9.1 ANI Pharmaceuticals Corporation Information
6.9.2 ANI Pharmaceuticals Description and Business Overview
6.9.3 ANI Pharmaceuticals Felbamate Sales, Revenue and Gross Margin (2016-2021)
6.9.4 ANI Pharmaceuticals Product Portfolio
6.9.5 ANI Pharmaceuticals Recent Developments/Updates

7 Felbamate Manufacturing Cost Analysis
7.1 Felbamate Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Felbamate
7.4 Felbamate Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Felbamate Distributors List
8.3 Felbamate Customers

9 Felbamate Market Dynamics
9.1 Felbamate Industry Trends
9.2 Felbamate Growth Drivers
9.3 Felbamate Market Challenges
9.4 Felbamate Market Restraints

10 Global Market Forecast
10.1 Felbamate Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Felbamate by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Felbamate by Type (2022-2027)
10.2 Felbamate Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Felbamate by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Felbamate by Application (2022-2027)
10.3 Felbamate Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Felbamate by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Felbamate by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Felbamate Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Felbamate Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Felbamate Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Felbamate Covered in This Study
Table 5. Global Felbamate Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Felbamate Sales Share by Manufacturers (2016-2021)
Table 7. Global Felbamate Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Felbamate Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Felbamate Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Felbamate Manufacturing Sites and Area Served
Table 11. Manufacturers Felbamate Product Type
Table 12. Global Felbamate Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Felbamate by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Felbamate as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Felbamate Sales by Region (2016-2021) & (K Units)
Table 16. Global Felbamate Sales Market Share by Region (2016-2021)
Table 17. Global Felbamate Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Felbamate Sales by Country (2016-2021) & (K Units)
Table 19. North America Felbamate Sales Market Share by Country (2016-2021)
Table 20. North America Felbamate Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Felbamate Revenue Market Share by Country (2016-2021)
Table 22. Europe Felbamate Sales by Country (2016-2021) & (K Units)
Table 23. Europe Felbamate Sales Market Share by Country (2016-2021)
Table 24. Europe Felbamate Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Felbamate Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Felbamate Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Felbamate Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Felbamate Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Felbamate Revenue Market Share by Region (2016-2021)
Table 30. Latin America Felbamate Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Felbamate Sales Market Share by Country (2016-2021)
Table 32. Latin America Felbamate Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Felbamate Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Felbamate Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Felbamate Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Felbamate Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Felbamate Revenue Market Share by Country (2016-2021)
Table 38. Global Felbamate Sales (K Units) by Type (2016-2021)
Table 39. Global Felbamate Sales Market Share by Type (2016-2021)
Table 40. Global Felbamate Revenue (Million US$) by Type (2016-2021)
Table 41. Global Felbamate Revenue Share by Type (2016-2021)
Table 42. Global Felbamate Price (US$/Unit) by Type (2016-2021)
Table 43. Global Felbamate Sales (K Units) by Application (2016-2021)
Table 44. Global Felbamate Sales Market Share by Application (2016-2021)
Table 45. Global Felbamate Revenue (Million US$) by Application (2016-2021)
Table 46. Global Felbamate Revenue Share by Application (2016-2021)
Table 47. Global Felbamate Price (US$/Unit) by Application (2016-2021)
Table 48. Mylan Corporation Information
Table 49. Mylan Description and Business Overview
Table 50. Mylan Felbamate Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Mylan Felbamate Product
Table 52. Mylan Recent Developments/Updates
Table 53. Alvogen Corporation Information
Table 54. Alvogen Description and Business Overview
Table 55. Alvogen Felbamate Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Alvogen Felbamate Product
Table 57. Alvogen Recent Developments/Updates
Table 58. Amneal Pharmaceuticals Corporation Information
Table 59. Amneal Pharmaceuticals Description and Business Overview
Table 60. Amneal Pharmaceuticals Felbamate Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Amneal Pharmaceuticals Felbamate Product
Table 62. Amneal Pharmaceuticals Recent Developments/Updates
Table 63. Sun Pharma Corporation Information
Table 64. Sun Pharma Description and Business Overview
Table 65. Sun Pharma Felbamate Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Sun Pharma Felbamate Product
Table 67. Sun Pharma Recent Developments/Updates
Table 68. Cadila Healthcare Corporation Information
Table 69. Cadila Healthcare Description and Business Overview
Table 70. Cadila Healthcare Felbamate Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Cadila Healthcare Felbamate Product
Table 72. Cadila Healthcare Recent Developments/Updates
Table 73. Merck Sharp and Dohme Corporation Information
Table 74. Merck Sharp and Dohme Description and Business Overview
Table 75. Merck Sharp and Dohme Felbamate Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Merck Sharp and Dohme Felbamate Product
Table 77. Merck Sharp and Dohme Recent Developments/Updates
Table 78. Schering Plough Corporation Information
Table 79. Schering Plough Description and Business Overview
Table 80. Schering Plough Felbamate Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Schering Plough Felbamate Product
Table 82. Schering Plough Recent Developments/Updates
Table 83. Corepharma Corporation Information
Table 84. Corepharma Description and Business Overview
Table 85. Corepharma Felbamate Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Corepharma Felbamate Product
Table 87. Corepharma Recent Developments/Updates
Table 88. ANI Pharmaceuticals Corporation Information
Table 89. ANI Pharmaceuticals Description and Business Overview
Table 90. ANI Pharmaceuticals Felbamate Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. ANI Pharmaceuticals Felbamate Product
Table 92. ANI Pharmaceuticals Recent Developments/Updates
Table 93. Production Base and Market Concentration Rate of Raw Material
Table 94. Key Suppliers of Raw Materials
Table 95. Felbamate Distributors List
Table 96. Felbamate Customers List
Table 97. Felbamate Market Trends
Table 98. Felbamate Growth Drivers
Table 99. Felbamate Market Restraints
Table 100. Global Felbamate Sales Forecast by Type (2022-2027) & (K Units)
Table 101. Global Felbamate Sales Market Share Forecast by Type (2022-2027)
Table 102. Global Felbamate Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 103. Global Felbamate Revenue Market Share Forecast by Type (2022-2027)
Table 104. Global Felbamate Sales Forecast by Application (2022-2027) & (K Units)
Table 105. Global Felbamate Sales Market Share Forecast by Application (2022-2027)
Table 106. Global Felbamate Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 107. Global Felbamate Revenue Market Share Forecast by Application (2022-2027)
Table 108. Global Felbamate Sales Forecast by Region (2022-2027) & (K Units)
Table 109. Global Felbamate Sales Market Share Forecast by Region (2022-2027)
Table 110. Global Felbamate Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 111. Global Felbamate Revenue Market Share Forecast by Region (2022-2027)
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Felbamate
Figure 2. Global Felbamate Market Share by Type in 2020 & 2027
Figure 3. Tablet Product Picture
Figure 4. Oral Solution Product Picture
Figure 5. Global Felbamate Market Share by Application in 2020 & 2027
Figure 6. Refractory Lennox-Gastaut Syndrome
Figure 7. Refractory Seizure Disorders
Figure 8. Others
Figure 9. Global Felbamate Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Felbamate Market Size 2016-2027 (US$ Million)
Figure 11. Global Felbamate Sales 2016-2027 (K Units)
Figure 12. Global Felbamate Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Felbamate Sales Share by Manufacturers in 2020
Figure 14. Global Felbamate Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Felbamate Players: Market Share by Revenue in 2020
Figure 16. Felbamate Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Felbamate Sales Market Share by Region (2016-2021)
Figure 18. Global Felbamate Sales Market Share by Region in 2020
Figure 19. Global Felbamate Revenue Market Share by Region (2016-2021)
Figure 20. Global Felbamate Revenue Market Share by Region in 2020
Figure 21. U.S. Felbamate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Felbamate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Felbamate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Felbamate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Felbamate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Felbamate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Felbamate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Felbamate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Felbamate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Felbamate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Felbamate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Felbamate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Felbamate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Felbamate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Felbamate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Felbamate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines Felbamate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam Felbamate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Felbamate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Felbamate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Felbamate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Felbamate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Felbamate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. UAE Felbamate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Felbamate by Type (2016-2021)
Figure 46. Sales Market Share of Felbamate by Application (2016-2021)
Figure 47. Sales Market Share of Felbamate by Application in 2020
Figure 48. Revenue Share of Felbamate by Application (2016-2021)
Figure 49. Revenue Share of Felbamate by Application in 2020
Figure 50. Manufacturing Cost Structure of Felbamate
Figure 51. Manufacturing Process Analysis of Felbamate
Figure 52. Felbamate Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed